United Therapeutics Chairperson, CEO Martine A. Rothblatt disposes of USD 4.3 million in common shares
United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at $117.76 on Oct. 9, 2026. Family trust sold 9,099 shares at prices from $531.92 to $550.7197 on the same day. Trust’s common stock stake ended at 324,443 shares. Disclaimer: This news brief was created by Public Tech